CIK 0001815442 · Large accelerated filer
Kymera Therapeutics, Inc.
Sign in to watch- Ticker
- KYMR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812992166
- Phone
- 857-285-5314
- Business address
- 500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN, MA, 02472
- Former names
- Kymera Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,158,214
- in 2 filings, $3.4M under 10b5-1 plans
Net −$4,158,214. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-31 | Mainolfi Nello Chief Executive Officer | Sale 10b5-1 | −23,986 | $77.95 | $1.9M | 669,091 |
| 2025-12-31 | Mainolfi Nello Chief Executive Officer | Sale 10b5-1 | −6,014 | $78.52 | $472K | 663,077 |
| 2025-12-31 | Mainolfi Nello Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −30,000 | 275,559 | ||
| 2025-12-17 | Mainolfi Nello Chief Executive Officer | Option exercise | +2,595 | $38.53 | $100K | 663,077 |
| 2025-12-17 | Mainolfi Nello Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −2,595 | 272,505 | ||
| 2025-12-17 | Esposito Pamela Director | Option exercise 10b5-1 | +12,563 | $49.10 | $617K | 12,563 |
| 2025-12-17 | Esposito Pamela Director | Option exercise 10b5-1 | +12,000 | $27.67 | $332K | 24,563 |
| 2025-12-17 | Esposito Pamela Director | Option exercise 10b5-1 | +3,000 | $31.20 | $94K | 27,563 |
| 2025-12-17 | Esposito Pamela Director | Sale 10b5-1 | −14,505 | $81.56 | $1.2M | 13,058 |
| 2025-12-17 | Esposito Pamela Director | Sale 10b5-1 | −7,959 | $82.34 | $655K | 5,099 |
| 2025-12-17 | Esposito Pamela Director | Sale 10b5-1 | −4,099 | $83.45 | $342K | 1,000 |
| 2025-12-17 | Esposito Pamela Director | Sale 10b5-1 | −1,000 | $84.07 | $84K | 0 |
| 2025-12-17 | Esposito Pamela Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,563 | 7,500 | ||
| 2025-12-17 | Esposito Pamela Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,000 | 0 | ||
| 2025-12-17 | Esposito Pamela Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,000 | 13,000 | ||
| 2025-12-12 | Booth Bruce Director | Sale | −570 | $91.04 | $52K | 3,974,481 |
| 2025-12-12 | Booth Bruce Director | Sale | −108 | $91.04 | $10K | 685,393 |
| 2025-12-11 | Booth Bruce Director | Sale | −5,125 | $91.23 | $468K | 3,975,051 |
| 2025-12-11 | Booth Bruce Director | Sale | −976 | $91.23 | $89K | 685,501 |
| 2025-12-11 | BAKER BROS. ADVISORS LP Director | Purchase | +167,192 | $86.00 | $14.4M | 701,326 |
Page 18 of 25 · 493 trades